James Rolke
About James Rolke
James Rolke is the Director and CEO of Revelation Biosciences, with 29 years of experience in the biotechnology industry, including significant roles in R&D and product approvals.
James Rolke: Director and CEO of Revelation Biosciences
James Rolke co-founded Revelation Biosciences and currently serves as its Director and CEO. He has played a pivotal role in leading the company, leveraging his extensive background in biotechnology to drive innovation. Under his leadership, Revelation Biosciences focuses on developing novel approaches and solutions in the field. His strategic vision has been instrumental in advancing the company's goals and objectives.
James Rolke's Career in the Biotechnology Industry
James Rolke brings a wealth of experience with 29 years in the biotechnology industry. His career includes significant contributions to several leading biotech companies. At La Jolla Pharmaceutical Company, he held various leadership roles, eventually serving as Chief Scientific Officer from 2017 to 2020. He has also been a key figure at Pluromed, Inc., Prospect Therapeutics, Inc., Mersana Therapeutics, Inc., GlycoGenesys, Inc., Surgical Sealants, Inc., GelTex, Inc., and Alpha-Beta Technology, Inc.
James Rolke's Contributions to Research and Development
During his tenure at La Jolla Pharmaceutical Company, James Rolke oversaw the development of multiple technologies, including six Investigational New Drugs (INDs) and two marketing approvals. Notable among these are Giapreza, approved by both the US FDA and EMEA for the treatment of distributive shock, and artesunate, approved for the treatment of severe malaria. His leadership in R&D has been marked by significant advancements in medical treatments and technologies.
James Rolke's Role at Pluromed, Inc.
As the Chief Technology Officer at Pluromed, Inc., James Rolke played a crucial role in the development and approval of two medical devices through the 510(k) and PMA approval pathways. His efforts contributed to the successful acquisition of Pluromed by Sanofi, underscoring his ability to bring innovative medical technologies to market.
James Rolke's Educational Background
James Rolke received his Bachelor of Science in Chemistry from Keene State College. His academic training laid the foundation for his extensive career in biotechnology, providing him with the knowledge and skills necessary to excel in the industry. His educational background has been instrumental in his ability to lead and innovate in various scientific roles.